Contact Us
Click here to contact Felicity Thomas,editor.
May 28, 2014
Minimally-invasive glaucoma surgery Micro-stent is safe and effective after 2-years A supracilliary micro-stent, when implanted in conjunction with cataract surgery, substantially reduces intraocular pressure (IOP) with minimal complications in patients with open-angle glaucoma (OAG), according to researchers in Germany and the US. More...
Treating rhegmatogenous RD in BD Scleral buckling or PPV can treat rhegmatogenous RD in BD Scleral buckling or pars plana vitrectomy (PPV) can be used to treat rhegmatogenous retinal detachment (RD) associated with Behçet's disease (BD), according to researchers in the Department of Ophthalmology, Zagazig University, Egypt. More...
Phase II study for glaucoma drug Dose-ranging study initiated for glaucoma candidate A Phase II dose-ranging study has been initiated for Amakem Therapeutics' glaucoma drug candidate AMA0076, a highly potent, locally acting Rho Kinase (ROCK) inhibitor designed to reduce intraocular pressure (IOP) while minimizing common ROCK inhibitor side effects such as hyperaemia. More...
Products in Practice Issue 3
Real world experience of leading ophthalmic products.
Read more:
Ranibizumab leading the anti-VEGF evolution
Considerations and new perspectives in anti-VEGF therapy.
Read more:
